알코올·약물중독US
New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial
New York Times - Health|2025.12.12
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.
The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.
원문 기사 보기New York Times - Health에서 원문을 확인할 수 있습니다
